Stockreport

Unicycive Therapeutics Receives Confirmatory Guidance on Renazorb Regulatory Pathway [MarketWatch]

Unicycive Therapeutics, Inc.  (UNCY) 
PDF clinical-stage biotechnology company developing therapies for patients with kidney disease, today provided an update on the development and regulatory filing pathway for [Read more]